Venaxis – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. EXCLUSIVE LICENSE AGREEMENT Between Washington University Licensor and AspenBio, Inc. Licensee (August 5th, 2010)
Introduction: This Agreement is made and entered into this 1st day of May, 2004 by and between The Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, having its principal office at One Brookings Drive, St. Louis, Missouri 63130, [through its School of Medicine] (hereinafter "WU") and AspenBio, Inc. with its principal offices at 1585 South Perry St., Castle Rock, CO 80104, hereinafter "Aspen". WU and Aspen may be referred to individually as a "Party" or collectively as the "Parties".
Venaxis – Exclusive License Agreement (August 13th, 2008)
This AGREEMENT is made effective as of this 2nd day of April, 2008 (the Effective Date), by and between Novartis Animal Health Inc, a corporation organized and existing under the laws of Switzerland and having its principal office at Schwarzwaldallee 215, 4058 Basel, Switzerland (hereinafter referred to as Novartis) and AspenBio Pharma, Inc, a corporation organized and existing under the laws of the State of Colorado, U.S.A., and having its principal office at 1585 South Perry Street, Castle Rock, Colorado 80104, United States of America (hereinafter referred to as Aspen).
Venaxis – Effective Date: January 15, 2004 OPTION AGREEMENT (May 4th, 2007)
This OPTION AGREEMENT (the Agreement) certifies that Strategic Growth International, Inc. (Holder), subject to the terms and conditions hereof, is entitled to purchase from AspenBio Pharma, Inc., f/k/a AspenBio, Inc., (the Company), 798,000 shares (the Option Shares) of Company common stock, no par value. This option, together with all options hereafter issued in exchange or substitution for this option, is referred to as the Option. The number of Option Shares is subject to adjustment as provided in Section 5 below. Notwithstanding anything to the contrary contained herein, this Option shall expire at 5:00 p.m. MST on January 15, 2009 (the Termination Date).
Venaxis – AMENDMENT No. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (January 26th, 2007)
THIS AMENDMENT is made to the EMPLOYMENT AGREEMENT dated as of the 1st day of February 2005, by and between, AspenBio Pharma, .Inc., (formerly AspenBio, Inc.) a Colorado corporation (the Employer or Company) and Richard G. Donnelly (the Executive).
Venaxis – Settlement Agreement and Release (April 18th, 2006)
This SETTLEMENT AGREEMENT AND RELEASE (Agreement) is entered into and deemed effective this 17th day of April 2006, by and between Roger Hurst (Hurst) and Diane Newman (Newman), on the one hand, and AspenBio, Inc. n/k/a AspenBio Pharma, Inc., a Colorado Corporation (AspenBio), on the other hand. Hurst, Newman, and AspenBio may be collectively referred to as the Parties.
Venaxis – Contract (August 12th, 2005)
EXHIBIT 10.1 ________________________________________________________________________________ COMMON STOCK AND WARRANT PURCHASE AGREEMENT for the purchase of Units Each Unit consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock of ASPENBIO, INC., May 12, 2005 ________________________________________________________________________________ TABLE OF CONTENTS ----------------- ARTICLE 1 DEFINITIONS..........................................................1 1.1 Certain Definitions..........................................1 1.2 Accounting Principles........................................4 1.3 O
Venaxis – Contract (January 25th, 2005)
Exhibit 10.25 (b) EXECUTIVE EMPLOYMENT AGREEMENT ------------------------------ THIS AGREEMENT dated as of the 24th day of January 2005, to be effective as of the 1st day of February 2005, by and between, AspenBio. Inc., a Colorado corporation (the "Employer" or "Company") and Richard G. Donnelly (the "Executive"). In consideration of the mutual covenants contained in this Agreement, the Employer agrees to employ the Executive and the Executive agrees to be employed by the Employer upon the terms and conditions hereinafter set forth. ARTICLE 1 TERM OF EMPLOYMENT ------------------ 1.1 Initial Term. The initial term of employment hereunder shall commence as of the effective day first written above ("Commencement Date") and shall continue for a period of one year from that date, unless terminated earlier as provided under A